The global prefilled syringes market is growing, due to increasing demand for vaccines, growing geriatric population, increasing prevalence of chronic and lifestyle associated diseases, and increasing healthcare expenditure. In addition, the technological advancement in prefilled syringes, regulations regarding needlestick injuries increases popularity of prefilled syringes, increasing injectable drugs pipeline, and increasing demand for point-of-care administration are also driving the growth of the global market.
On the basis of type, the glass prefilled syringes segment is expected to be the largest market; while plastic prefilled syringes segment would witness the fastest growth during the forecast period with a CAGR of 20.2%.
Request to sample: https://www.psmarketresearch.com/market-analysis/prefilled-syringes-market/report-sample
However, strict regulatory requirements, recall of prefilled syringes, interaction of prefilled syringe with drugs, alternative drug delivery methods, and manufacturing complexity and high cost of prefilled syringe act as hindrance in the growth of the global market of prefilled syringes. The increasing combination therapies and customized prefilled syringes are the latest trends observed in this market.
Send Enquiry: https://www.psmarketresearch.com/send-enquiry?enquiry-url=prefilled-syringes-market
The key companies operating in the global prefilled syringes market include Becton, Dickinson and Company, SCHOTT AG, Gerresheimer AG, Unilife Corporation, Nipro Corporation, Baxter International Inc., West Pharmaceutical Services Inc., Ypsomed Holding AG, Stevanato Group S.p.a., Vetter Pharma-Fretigung GmbH & Co., and Bespak Europe Ltd.